Tyshenko Michael G
University of Ottawa, Ottawa, Canada.
Bioethics. 2007 Sep;21(7):364-9. doi: 10.1111/j.1467-8519.2007.00571.x.
A recent approach for bioterrorism risk management calls for stricter regulations over biotechnology as a way to control subversion of technology that may be used to create a man-made pandemic. This approach is largely unworkable given the increasing pervasiveness of molecular techniques and tools throughout society. Emerging technology has provided the tools to design much deadlier pathogens but concomitantly the ability to respond to emerging pandemics to reduce mortality has also improved significantly in recent decades. In its historical context determining just how 'risky' biological weapons is an important consideration for decision making and resource allocation. Management should attempt to increase capacity, share resources, provide accurate infectious disease reporting, deliver information transparency and improve communications to help mitigate the magnitude of future pandemics.
最近一种生物恐怖主义风险管理方法要求对生物技术实施更严格的监管,以此作为控制可能被用于制造人为大流行病的技术颠覆的一种方式。鉴于分子技术和工具在全社会日益普及,这种方法在很大程度上是行不通的。新兴技术提供了设计更致命病原体的工具,但与此同时,近几十年来应对新兴大流行病以降低死亡率的能力也有了显著提高。从历史背景来看,确定生物武器究竟有多“危险”是决策和资源分配的一个重要考量因素。管理层应努力提高能力、共享资源、提供准确的传染病报告、实现信息透明并改善沟通,以帮助减轻未来大流行病的影响程度。